LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
104,426,400
Share change
-999,998
Total reported value
$1,253,163,056
Put/Call ratio
39%
Price per share
$12.00
Number of holders
114
Value change
-$371,540
Number of buys
53
Number of sells
48

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2018

As of 30 Jun 2018, LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 104,426,400 shares. The largest 10 holders included Artal Group S.A., FMR LLC, BlackRock Inc., UBS ASSET MANAGEMENT AMERICAS INC, VANGUARD GROUP INC, NEA Management Company, LLC, STATE STREET CORP, CLEARBRIDGE, LLC, SECTOR GAMMA AS, and PINNACLE ASSOCIATES LTD. This page lists 114 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.